Prothena Corp PLC (PRTA)

Add to Watchlists

Create an Alert

Quickflows

11.36 -0.13 -1.13% NASDAQ Oct 28, 09:54 USD

Prothena News

Wire

Headline

Time (ET)
MT Newswires

Midday Report: Wall Street Slightly Higher; Snap Hits Record High

10/21 12:46
Yahoo

Prothena (PRTA) to Advance Parkinson's Disease Drug to Phase II

10/21 10:48
MT Newswires

Analyst Actions: Cantor Fitzgerald Adjusts Prothena's Price Target to $24 From $20, Keeps at Overweight

10/21 08:33
Yahoo

The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings

10/21 08:04
MT Newswires

Prothena, Roche to Advance Prasinezumab into Late-Stage Trial in Parkinson's Disease -- Stock Jumps 11% After-Hours

10/20 17:54
SA Breaking News

Roche to advance development of Parkinson's candidate despite underwhelming data

10/20 16:44
Globe Newswire

Roche and Prothena will Advance Prasinezumab into Late-Stage Clinical Development Study in Parkinson’s Disease

10/20 16:05
Globe Newswire

Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

10/02 16:05
Yahoo

Hedge Funds Never Been This Bullish On Prothena Corporation plc (PRTA)

09/29 14:35
Globe Newswire

Prothena to Hold Investor Webcast to Discuss Results from Phase 2 PASADENA Study Presented at the International Parkinson and Movement Disorder Society's MDS Virtual Congress

09/15 08:30
Yahoo

Prothena to Hold Investor Webcast to Discuss Results from Phase 2 PASADENA Study Presented at the International Parkinson and Movement Disorder Society's MDS Virtual Congress

09/15 08:30
SA Breaking News

Seeking Alpha Catalyst Watch

09/11 15:30
MT Newswires

Prothena Says Parkinson's Disease Treatment Fails to Meet Primary Endpoint But Drug May Slow Disease Progression

09/11 10:59
Globe Newswire

Prasinezumab Slows Progression on Measures of Parkinson’s Disease in Phase 2 Study

09/11 08:30
Globe Newswire

Prothena to Present at the 2020 Cantor Virtual Global Healthcare Conference on September 15

09/08 16:05
Yahoo

Prothena (PRTA) Up 2.9% Since Last Earnings Report: Can It Continue?

09/05 11:31
Globe Newswire

Prothena Announces Updated Timing of Presentation for Phase 2 PASADENA Study Results at International Congress of Parkinson’s Disease and Movement Disorders

09/03 16:05
Globe Newswire

Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

09/02 16:05
MT Newswires

--Analyst Actions: Oppenheimer Lifts Prothena PT to $18 From $16, Maintains Outperform Rating

08/10 11:14
Yahoo

Prothena (PRTA) Reports Q2 Loss, Tops Revenue Estimates

08/06 20:10

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial

{{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.